Accustem Sciences Inc
AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to … Read more
Accustem Sciences Inc (ACUT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.208x
Based on the latest financial reports, Accustem Sciences Inc (ACUT) has a cash flow conversion efficiency ratio of 0.208x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-604.13K) by net assets ($-2.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Accustem Sciences Inc - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Accustem Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Accustem Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Accustem Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Diamond Estates Wines & Spirits Inc
PINK:DWWEF
|
0.015x |
|
Hanover House Inc.
PINK:HHSE
|
0.002x |
|
PHI Group Inc
PINK:PHIL
|
0.032x |
|
Tony G Co-Investment Holdings Ltd
PINK:BGRDF
|
0.550x |
|
Roctool
PA:ALROC
|
-0.001x |
|
Kein Hing International Bhd
KLSE:7199
|
0.101x |
|
Aages SA
RO:AAG
|
N/A |
|
Lee Swee Kiat Group Bhd
KLSE:8079
|
0.062x |
Annual Cash Flow Conversion Efficiency for Accustem Sciences Inc (2022–2024)
The table below shows the annual cash flow conversion efficiency of Accustem Sciences Inc from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-3.31 Million | $-664.07K | 0.200x | -73.80% |
| 2023-12-31 | $-2.11 Million | $-1.62 Million | 0.765x | -94.09% |
| 2022-12-31 | $-139.55K | $-1.81 Million | 12.942x | -- |